Personalized PRRT improves radiation delivery to neuroendocrine tumors

Via Top Health News -- ScienceDaily

Neuroendocrine cancer is exceedingly difficult to manage and unlikely to be cured, but researchers intend to slow progression of these tumors and aid survival by personalizing patient dose of peptide-receptor radionuclide therapy (PRRT), according to research.

View original post here:

%d bloggers like this: